Refinement of triple-negative breast cancer molecular subtypes: Implications for neoadjuvant chemotherapy selection

Brian D. Lehmann, Bojana Jovanović, Xi Chen, Monica V. Estrada, Kimberly N. Johnson, Yu Shyr, Harold L. Moses, Melinda E. Sanders, Jennifer A. Pietenpol

Research output: Contribution to journalArticlepeer-review

498 Scopus citations

Fingerprint

Dive into the research topics of 'Refinement of triple-negative breast cancer molecular subtypes: Implications for neoadjuvant chemotherapy selection'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds